TrialRheumatology (Oxford, England)2020

Efficacy and safety of upadacitinib in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE): a placebo-controlled phase IIb/III study.

Hideto Kameda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.